Knowledge, Reporting, & Uptake
Sheng J, Feldhake E, Zarin DA, Kimmelman J. Completeness of clinical evidence citation in trial protocols: A cross-sectional analysis. Med. 2022 Apr 8.
Hutchinson N, Klas K, Carlisle BG, Kimmelman J, Waligora M. How Informative were Early SARS-CoV-2 Treatment and Prevention Trials? A longitudinal cohort analysis of trials registered on clinicaltrials. gov. Plos one. 2022 Jan 21.
Zarin DA, Goodman SN, Kimmelman J. Harms From Uninformative Clinical Trials. JAMA, 2019.
Hakala A, Fergusson D, Kimmelman J. Nonpublication of trial results for new neurological drugs: A systematic review. Annals of Neurology, 2017.
Hakala A, Fergusson D, Carlisle B, Kimmelman J. Accessibility of Trial Reports for Drugs Stalling in Clinical Development. The BMJ, 2015.
Hey SP. Ethics and Epistemology of Accurate Prediction in Clinical Research. Journal of Medical Ethics, 2015.
Hey SP, Kimmelman J. The Risk-Escalation Model: A Principled Design Strategy for Early-Phase Trials. Kennedy Institute of Ethics Journal, 2014.
Freeman GA, Kimmelman J, Dancey J, Monzon JG. Reporting practices of pharmacodynamic studies involving invasive research procedures in cancer trials. British Journal of Cancer, 2013.
Freeman GA and Kimmelman J. Publication and Reporting Conduct for Pharmacodynamic Analyses of Tumor Tissue in Early Phase Oncology Trials. Clinical Cancer Research, 2012.
Kimmelman J, Anderson JA. Should Preclinical Studies be Registered? Nature Biotechnology, 2012.